Nordic Nanovector begins Phase 1b trial of Betalutin and Rituximab combo for follicular lymphoma

Nordic Nanovector has commenced the dosing of the first patient in its Phase 1b clinical trial, dubbed Archer-1, which aims to evaluate the combination of ... Read More